Insider Holders & Insider Ownership - Viracta Therapeutics Inc. (VIRX)

List of insiders holdings for Viracta Therapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
# Insider Holder Name Report
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
1 aMoon 2 Fund Limited Partnership
Schindel Yair Chaim
10% Owner
2023-01-10 17:21:23 7,392,237
0
7,392,237 Form 13D
2 BARRETT M JAMES
10% Owner
2014-08-29 17:38:16 0
4,659,333
4,659,333 Form 4
3 BARRIS PETER J
10% Owner
2014-08-29 17:39:04 0
4,659,333
4,659,333 Form 4
4 BASKETT FOREST
10% Owner
2014-08-29 17:39:39 0
4,659,333
4,659,333 Form 4
5 SANDELL SCOTT D
10% Owner
2014-08-29 17:42:34 0
4,659,333
4,659,333 Form 4
6 KOLLURI KRISHNA KITTU
10% Owner
2014-08-29 17:41:57 0
4,659,333
4,659,333 Form 4
7 KERINS PATRICK J
10% Owner
2014-08-29 17:41:25 0
4,659,333
4,659,333 Form 4
8 DRANT RYAN D
10% Owner
2014-08-29 17:40:41 0
4,659,333
4,659,333 Form 4
9 TRAINOR III EUGENE A
10% Owner
2009-11-03 16:52:58 0
4,331,159
4,331,159 Form 4
10 LINEHAN CHARLES M
10% Owner
2009-11-03 16:52:42 0
4,331,159
4,331,159 Form 4
11 Semon Dominique
10% Owner
2010-05-04 18:36:33 0
3,921,095
3,921,095 Form 4
12 MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
UBS Oncology Impact Fund L.P.
10% Owner
2020-02-05 14:13:34 2,809,912
0
2,809,912 Form 13G
13 BAY CITY CAPITAL LLC
Bay City Capital Management V LLC
Bay City Capital Fund V L.P.
Bay City Capital Fund V Co-Investment Fund L.P.
10% Owner
2017-11-07 16:02:35 1,828,968
0
1,828,968 Form 13D
14 WARBURG PINCUS EQUITY PARTNERS LP
WARBURG PINCUS & CO
Warburg Pincus Partners LLC
WARBURG PINCUS LLC
10% Owner
2009-11-09 16:20:47 1,671,885
0
1,671,885 Form 13D
15 MAYFIELD IX
MAYFIELD IX MANAGEMENT LLC
MAYFIELD ASSOCIATES FUND III L P
MAYFIELD VIII MANAGEMENT LLC
UNGER WILLIAM D
AUKEN WENDELL G VAN III
FONG KEVIN A
MYERS FRANK G JR
DALAL YOGEN K
HEIDRICH A GRANT III
10% Owner
2007-02-13 17:15:27 1,298,784
0
1,298,784 Form 13G
16 CREDIT SUISSE
CREDIT SUISSE FIRST BOSTON EQUITY PARTNERS L.P.
CREDIT SUISSE FIRST BOSTON EQUITY PARTNERS (BERMUDA) L.P.
EMA PARTNERS FUND 2000 L.P.
EMA PRIVATE EQUITY FUND 2000 L.P.
CREDIT SUISSE FIRST BOSTON U.S. EXECUTIVE ADVISORS L.P.
CREDIT SUISSE FIRST BOSTON ADVISORY PARTNERS LLC
CREDIT SUISSE FIRST BOSTON (BERMUDA) LTD
HEMISPHERE PRIVATE EQUITY PARTNERS LTD.
HEMISPHERE PRIVATE EQUITY PARTNERS CHARITABLE TRUST
10% Owner
2010-02-16 15:09:55 1,206,590
0
1,206,590 Form 13G
17 ROYSTON IVOR
Director
2024-11-27 16:08:36 890,179
18,599
908,778 Form 4
18 ALTA BIOPHARMA PARTNERS III LP
ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG
ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC
ALTA BIOPHARMA MANAGEMENT III LLC
PENHOET EDWARD
DELEAGE JEAN
CHAMPSI FARAH
Former 10% Owner
2015-02-12 16:12:09 832,909
0
832,909 Form 13G
19 ALTA BIOPHARMA PARTNERS III LP
MARDUEL ALIX
PENHOET EDWARD
ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG
ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC
ALTA BIOPHARMA MANAGEMENT III LLC
DELEAGE JEAN
CHAMPSI FARAH
10% Owner
2015-02-12 16:12:09 832,909
0
832,909 Form 13G
20 Faerm Michael E.
Chief Financial Officer
2024-05-16 16:26:48 500,000
0
500,000 Form 4
21 Quinn William P.
See Remarks
2020-04-02 15:30:39 487,697
0
487,697 Form 4
22 Rothera Mark
President and CEO
2024-03-13 20:36:16 475,000
0
475,000 Form 4
23 Fox Judith A.
See Remarks
2020-04-02 15:25:35 457,500
0
457,500 Form 4
24 DePinto Joseph I
EVP, CCO
2014-03-04 20:52:09 300,000
0
300,000 Form 4
25 Aisling Capital IV LP
Aisling Capital Partners IV LLC
Aisling Capital Partners IV LP
SCHIFF ANDREW N
ELMS STEVE
10% Owner
2022-02-14 12:14:03 288,571
0
288,571 Form 13G
26 EVNIN ANTHONY B
Director
2009-04-07 15:07:27 0
266,532
266,532 Form 4
27 Burcar Melody
Senior VP, Finance
2024-03-22 16:07:14 260,750
0
260,750 Form 3
28 Swisher Daniel N JR
President and CEO
2017-07-12 17:32:00 257,759
0
257,759 Form 4
29 Chevallard Daniel R.
CFO and COO
2024-03-13 20:29:45 200,000
0
200,000 Form 4
30 Rojkjaer Lisa
Chief Medical Officer
2023-03-17 17:03:25 150,000
0
150,000 Form 4
31 Pomerantz Roger
Director
2024-11-27 16:06:38 144,547
0
144,547 Form 4
32 Cohen Darrel P.
Chief Medical Officer
2024-03-13 20:33:00 120,000
0
120,000 Form 4
33 BJERKHOLT ERIC
EVP, CFO & Corp. Secretary
2016-12-06 19:57:31 95,000
0
95,000 Form 4/A
34 Gullotta Tina
VP, Finance
2020-06-05 15:18:29 90,500
0
90,500 Form 4
35 ADELMAN DANIEL C MD
Sr. VP, Development and CMO
2007-09-14 17:40:07 90,000
0
90,000 Form 4
36 Roshwalb Gur
Director
10% Owner
2021-03-30 20:18:29 80,000
0
80,000 Form 4
37 Pierce Valerie L
SVP & General Counsel
2008-07-02 20:23:01 67,500
0
67,500 Form 4/A
38 Ketchum Steven B
Director
2020-07-01 16:45:25 60,000
0
60,000 Form 4
39 Misfeldt Dayton
See Remarks
2020-07-01 17:15:03 60,000
0
60,000 Form 4
40 Pearce Homer L
Director
2020-07-01 17:08:17 60,000
0
60,000 Form 4
41 Wolff Henry Ward
Director
2020-07-01 16:55:11 60,000
0
60,000 Form 4
42 YOUNG JAMES W
Director
2020-07-01 16:52:52 60,000
0
60,000 Form 4
43 Carchedi Steve
Director
2020-07-01 16:46:35 60,000
0
60,000 Form 4
44 STUMP DAVID C
Director
2020-07-01 16:39:22 60,000
0
60,000 Form 4
45 McDowell Robert Scott
Vice President, Research
2007-09-14 18:57:50 60,000
0
60,000 Form 4
46 Hyare Parvinder S
See Remarks
2021-01-07 18:01:01 55,550
0
55,550 Form 3
47 Borellini Flavia
Director
2024-06-24 19:49:14 50,000
0
50,000 Form 4
48 Barlow Jane F
Director
2024-06-24 19:43:06 50,000
0
50,000 Form 4
49 Simon Barry J.
Director
2024-06-24 19:44:18 50,000
0
50,000 Form 4
50 DARCY THOMAS E
Director
2024-06-24 19:46:16 50,000
0
50,000 Form 4
51 Rubino Stephen
Director
2024-06-24 19:39:12 50,000
0
50,000 Form 4
52 Murphy Samuel Lafayette
Director
2024-06-24 19:47:16 50,000
0
50,000 Form 4
53 Chung Jane
Director
2024-06-24 19:48:13 50,000
0
50,000 Form 4
54 Fust Matthew
Director
2016-07-05 18:25:14 50,000
0
50,000 Form 4
55 Winter Daryl B
SVP of I.P./Corp. Secretary
2006-12-04 16:52:24 45,000
0
45,000 Form 4
56 ONETTO NICOLE
Director
2022-06-10 17:07:48 40,000
0
40,000 Form 4
57 Huang Michael
Director
2022-06-10 16:59:21 40,000
0
40,000 Form 4
58 Kim Helen Susan
Director
2015-07-01 21:09:48 40,000
0
40,000 Form 4
59 Parker Geoffrey M.
Director
2017-06-02 17:22:40 25,000
0
25,000 Form 4
60 Craig Adam R
EVP, Development & CMO
2015-03-02 19:49:31 23,452
0
23,452 Form 4
61 HURWITZ EDWARD
Director
2013-07-02 18:56:47 20,000
0
20,000 Form 4
62 LEFF JONATHAN S
Director
10% Owner
2008-06-05 16:52:07 10,000
0
10,000 Form 4
63 FODOR STEPHEN P A
Director
2008-06-05 17:10:15 10,000
0
10,000 Form 4
64 Wells James A
Director
2008-06-05 17:19:39 10,000
0
10,000 Form 4
65 GOLDBY STEVEN D
Director
2008-06-06 14:31:16 10,000
0
10,000 Form 4
66 HIRSCH RUSSELL C
Director
2005-09-27 07:56:05 0
0
0 Form 3
67 BIOGEN IDEC INC
BIOGEN IDEC MA INC
10% Owner
2012-02-13 16:08:04 0
0
0 Form 13G
68 Growth Equity Opportunities Fund LLC
New Enterprise Associates 12 Limited Partnership
NEA Partners 12 Limited Partnership
NEA 12 GP LLC
10% Owner
2021-03-10 21:40:22 0
0
0 Form 13D
69 Growth Equity Opportunities Fund LLC
New Enterprise Associates 12 Limited Partnership
NEA 12 GP LLC
NEA Partners 12 Limited Partnership
NEWHALL CHARLES W III
KRAMLICH C RICHARD
BARRIS PETER J
PERRY MARK W
BARRETT M JAMES
SANDELL SCOTT D
10% Owner
2021-03-10 21:40:22 0
0
0 Form 13D